Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium selenium for functional and cognitive outcomes after ischemic stroke
IRCT20170104031773N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selenium in ischemic stroke, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Functional scores and Cognitive scores. Started Apr 2019; status: completed.
02
Drugs
selenium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20170104031773N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170104031773N3.